Use of targeted therapy, healthcare costs, and survival with large panel testing, narrow testing, or no molecular testing in patients with metastatic non-small cell lung cancer (mNSCLC).

Wiedower, Julie; Zhang, Nicole; Forbes, Shaun P.; Clemens, Keelia; Weipert, Caroline; McNeal, A. Scott; Stockl, Karen M.; Tucker, Jamie; Certa, Julia M.; Morin, Pamela

doi:10.1200/jco.2025.43.16_suppl.8642

Use of targeted therapy, healthcare costs, and survival with large panel testing, narrow testing, or no molecular testing in patients with metastatic non-small cell lung cancer (mNSCLC).

NobleIDNI1P27W36R75S16

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E8EA5926.svg?ark=w1%2F20260521%2FE8EA5926&value=id)](https://nobleid.org/work/w1/20260521/E8EA5926)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Use of targeted therapy, healthcare costs, and survival with large panel testing, narrow testing, or no molecular testing in patients with metastatic non-small cell lung cancer (mNSCLC).

NobleIDNI1P27W36R75S16

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E8EA5926.svg?ark=w1%2F20260521%2FE8EA5926&value=id)](https://nobleid.org/work/w1/20260521/E8EA5926)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work